CD47-targeted Therapies For The Treatment Of Infectious Disease Read more about CD47-targeted Therapies For The Treatment Of Infectious Disease US Application 61/761,133Filed on 2013-02-05
Structure-based Design Of A Fusion Glycoprotein Vaccine For Metapneumovirus Read more about Structure-based Design Of A Fusion Glycoprotein Vaccine For Metapneumovirus US Application 62/096,744Filed on 2014-12-24
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE Read more about MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE US Application 62/120,353Filed on 2015-02-24
RECOMBINANT PARAMYXOVIRUSES AND THEIR USE Read more about RECOMBINANT PARAMYXOVIRUSES AND THEIR USE US Application 62/105,667Filed on 2015-01-20
Compositions and Methods for Inhibiting Human Immunodeficiency Virus Budding Read more about Compositions and Methods for Inhibiting Human Immunodeficiency Virus Budding US Application 62/030,193Filed on 2014-07-29
Compounds For Inhibiting 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase Read more about Compounds For Inhibiting 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase US Application 61/503,736Filed on 2011-07-01
Recombinant Respiratory Syncytial Virus (RSV) Strains with Mutations in the M2-2 ORF Providing A Range of Attenuation Phenotypes Read more about Recombinant Respiratory Syncytial Virus (RSV) Strains with Mutations in the M2-2 ORF Providing A Range of Attenuation Phenotypes US Application 62/266,199Filed on 2015-12-11
Chimeric Antigen Receptor To Control HIV Infection Read more about Chimeric Antigen Receptor To Control HIV Infection US Application 62/040,398Filed on 2014-08-21
NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE US Application 62/032,886Filed on 2014-08-04
Polyvalent Influenza Virus-Like Particles (VLPs) And Use as Vaccines Read more about Polyvalent Influenza Virus-Like Particles (VLPs) And Use as Vaccines US Application 62/014,821Filed on 2014-06-20